Understanding the Risks While B12 injections are considered very safe, how theyre administered makes all the difference
The workshop will include comprehensive sessions examining regulatory pathways and clinical context, API characterization and manufacturing, oral formulation development, device design and human factors, and drug-device integration strategies
it produces unreliable data that wastes the entire study investment
The Phase III clinical SURMOUNT-1 (NCT04184622) for tirzepatide, is expected to be completed in the first half of 2024
Gomez D, Logan JK, Tang C, Liao Z, Lee JJ, Heymach JV, Swisher SG , Welsh JW, Zhang J, Lin SH
The timeline for weight loss effects reflects this, with meaningful appetite changes emerging at 4 to 8 weeks of escalating doses